Moreover, among the semiquantitative PET parameters, SUVmax was higher in patients with BC HER2+ than in those with BC HER2−, but SUVmax was able to differentiate between IHC0 and IHC1–2–3 lesions only [36,37]. Here, ERBB2 is linked to breast cancer.